Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BL84ZA
|
|||
| Binder Name |
Vecuronium bromide
|
|||
| Synonyms |
Norcuron; ORG NC 45; Vecuronii bromidum; Bromuro de vecuronio; Vecuronium (bromide); Bromure de vecuronium; UNII-7E4PHP5N1D; ORG-NC 45; 7E4PHP5N1D; acetate;bromide; MFCD00867762; DSSTox_CID_3736; DSSTox_RID_77174; DSSTox_GSID_23736; NC-45; Vecuronii bromidum [INN-Latin]; NCGC00167467-01; Bromure de vecuronium [INN-French]; Bromuro de vecuronio [INN-Spanish]; EINECS 256-723-9; C34H57N2O4.Br; vecronium bromide; Norcuron (TN); Vecuronium bromide [USAN:USP:INN:BAN:JAN]; SCHEMBL22250; MLS001424317; CHEMBL1200629; DTXSID1023736; HY-B0118A; HMS2052I21; HMS3715L15; HMS3884C15; BCP06528; Vecuronium bromide (JAN/USP/INN); Tox21_112471; AKOS005145904; AKOS007930694; Tox21_112471_1; AC-2000; CCG-101147; CS-1881; MCULE-7004468628; NC00397; NE47510; NCGC00167467-03; DS-12625; SMR000471625; AB0013312; S1405; D00767; Pancuronium bromide impurity, vecuronium bromide -; SR-01000763634; Q-101014; SR-01000763634-3; Q27108523; Z1551429734; Vecuronium bromide, European Pharmacopoeia (EP) Reference Standard; Vecuronium bromide, United States Pharmacopeia (USP) Reference Standard; 1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C34H57BrN2O4
|
|||
| Canonical SMILES |
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
|
|||
| InChI |
1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1
|
|||
| InChIKey |
VEPSYABRBFXYIB-PWXDFCLTSA-M
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:9940
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.